More Patients Can Benefit From Functional Interventions for Parkinson’s, Essential Tremor (Podcast)

Focused ultrasound offers a newer alternative to deep brain stimulation

Surgical intervention for movement disorders, although rapidly advancing with new technologies, is still woefully underused. Only about 10% of surgical candidates actually undergo surgery to improve their condition.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

However, focused ultrasound and other new therapies may entice more patients to consider functional interventions for essential tremor and Parkinson’s disease, notes Benjamin Walter, MD, who leads the movement disorders and deep brain stimulation programs in Cleveland Clinic’s Neurological Institute.

Dr. Walter explores issues in surgical decision making in the newest episode of Cleveland Clinic’s peer-to-peer Neuro Pathways podcast. During the audio interview, he discusses:

  • Which patients with movement disorders are the best candidates for surgery
  • How to determine the right intervention for each patient
  • Using telemedicine for consultation, diagnosis and care planning
  • Novel technologies on the horizon

Click the player below to listen to the podcast now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at or wherever you get your podcasts.


Excerpt from the podcast

Dr. Walter: Focused ultrasound is a nonsurgical approach, yet it’s still an intervention on the brain. One limitation is that focused ultrasound can be done only on one side. So we target it to patients whose disease mostly impacts their dominant hand. They can’t write. They can’t keep food on a fork or spoon. They can’t drink from a cup. They may not be able to dress themselves or put on makeup. They might have trouble with their work, all because of that one hand.

If their impairment is in both hands, and they desire improvement in both hands, then deep brain stimulation is the only way to achieve that.

There is no hardware implanted in focused ultrasound. You don’t have a pacemaker, and there’s no upkeep necessary. In contrast, deep brain stimulation is a pacemaker for the brain. It’s programmable and adjustable, so we can change the settings and give patients further improvement as the disease progresses.

Deep brain stimulation is also reversible. Focused ultrasound is not. Some people have a healing phase in the first week or so after focused ultrasound, but if they have a side effect after that time, it tends to be permanent because focused ultrasound precisely places a lesion in the brain. Deep brain stimulation, while a surgical procedure, does not interrupt brain tissues except to pass a tiny wire into one location. Really, all the benefits and side effects of deep brain stimulation after the initial procedure come from turning it on, which is completely adjustable.


However, with deep brain stimulation, there’s a risk of a bleed in the brain, infection and hardware breakdown. Focused ultrasound doesn’t have those particular risks.

As you can see, there are pros and cons to the two procedures. One may be perfect for one patient and one may be perfect for another, depending on each patient’s treatment goals and risk tolerance.

Related Articles

Neurotrauma Guidelines: Where They’ve Been, Where They’re Headed and How to Make the Most of Them

Q&A with Brain Trauma Foundation guideline architect Gregory Hawryluk, MD, PhD

20-NEU-2020111 neuroimmunology_650x450
Autoimmune Neurologic Disorders: Treatable Conditions That Should Not Be Missed

Q&A with newly arrived autoimmune neurology specialist Amy Kunchok, MD

20-NEU-1984276 multimodal-monitoring_650x450
Multimodal Monitoring in the Neuro ICU: Essentials for Clinicians (Podcast)

A neurocritical care specialist shares what’s spurring growth of this new evaluation approach

central vein sign in multiple sclerosis
New Frontiers in Diagnosing and Monitoring Multiple Sclerosis (Podcast)

Get ready for central vein sign and optical coherence tomography

CGRP Antagonists for Decreasing Migraine Frequency: A Primer

How these new drugs fit into practice two years out from their first approvals

20-NEU-1892171 CQD_650x450_CCC-1901608_06-03-20_0443
What’s Afoot and What’s Ahead for Physical Medicine and Rehabilitation

A conversation on the state of physiatry with the AAPM&R’s Vice President

20-NEU-1851929 trigeminal-neuralgia-patient_650x450
Trigeminal Neuralgia: A Primer on Diagnosis and Treatment (Podcast)

Pharmacologic, procedural and surgical treatments abound